SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-084391
Filing Date
2021-03-18
Accepted
2021-03-17 20:10:31
Documents
4
Effectiveness Date
2021-03-18

Document Format Files

Seq Description Document Type Size
1 S-8 d24865ds8.htm S-8 47002
2 EX-5.1 d24865dex51.htm EX-5.1 5732
3 EX-23.1 d24865dex231.htm EX-23.1 1460
4 GRAPHIC g24865g24f88.jpg GRAPHIC 3045
  Complete submission text file 0001193125-21-084391.txt   59532
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-254420 | Film No.: 21752540
SIC: 2834 Pharmaceutical Preparations